$437 Million is the total value of SECTOR GAMMA AS's 31 reported holdings in Q4 2022. The portfolio turnover from Q3 2022 to Q4 2022 was 45.2% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| GILD | Sell | GILEAD SCIENCES INC | $51,169,691 | -6.1% | 596,036 | -32.5% | 11.70% | -16.7% |
| INCY | Sell | INCYTE CORP | $33,050,636 | +18.4% | 411,487 | -1.7% | 7.56% | +5.1% |
| CAH | Sell | CARDINAL HEALTH INC | $27,202,141 | +13.7% | 353,872 | -1.3% | 6.22% | +0.9% |
| BMY | Buy | BRISTOL-MYERS SQUIBB CO | $27,173,285 | +8.1% | 377,669 | +6.8% | 6.21% | -4.1% |
| ANTM | Buy | ELEVANCE HEALTH INC | $24,508,168 | +17.2% | 47,777 | +3.8% | 5.60% | +4.0% |
| MRK | Sell | MERCK & CO INC | $22,112,335 | +1.4% | 199,300 | -21.3% | 5.06% | -10.0% |
| MDT | Buy | MEDTRONIC PLC | $21,562,248 | -1.1% | 277,435 | +2.8% | 4.93% | -12.2% |
| ZBH | Sell | ZIMMER BIOMET HOLDINGS INC | $19,649,790 | +13.2% | 154,116 | -7.2% | 4.49% | +0.4% |
| BIIB | Sell | BIOGEN INC | $19,395,200 | -34.1% | 70,039 | -36.5% | 4.43% | -41.5% |
| LH | New | LABORATORY CORP AMER HLDGS | $17,542,318 | – | 74,496 | +100.0% | 4.01% | – |
| BMRN | Buy | BIOMARIN PHARMACEUTICAL INC | $16,041,881 | +72.7% | 155,009 | +41.4% | 3.67% | +53.2% |
| CNC | Sell | CENTENE CORP DEL | $15,163,731 | -3.3% | 184,901 | -8.3% | 3.47% | -14.2% |
| SGEN | Buy | SEAGEN INC | $13,648,662 | +17.7% | 106,207 | +25.3% | 3.12% | +4.4% |
| BSX | Sell | BOSTON SCIENTIFIC CORP | $13,639,656 | -9.0% | 294,784 | -23.9% | 3.12% | -19.3% |
| BRKR | Sell | BRUKER CORP | $13,121,970 | +3.9% | 191,982 | -19.3% | 3.00% | -7.8% |
| EW | New | EDWARDS LIFESCIENCES CORP | $13,000,942 | – | 174,252 | +100.0% | 2.97% | – |
| QGEN | Buy | QIAGEN NV | $11,643,299 | +38.2% | 233,473 | +14.4% | 2.66% | +22.6% |
| BAX | Buy | BAXTER INTL INC | $11,268,855 | +23.8% | 221,088 | +30.8% | 2.58% | +9.8% |
| ILMN | New | ILLUMINA INC | $9,604,500 | – | 47,500 | +100.0% | 2.20% | – |
| THC | New | TENET HEALTHCARE CORP | $9,560,596 | – | 195,954 | +100.0% | 2.19% | – |
| CI | Sell | CIGNA CORP NEW | $7,372,978 | -47.4% | 22,252 | -56.0% | 1.69% | -53.3% |
| NUVA | Sell | NUVASIVE INC | $7,169,244 | -34.2% | 173,842 | -30.1% | 1.64% | -41.6% |
| BIO | Buy | BIO RAD LABS INCcl a | $6,722,794 | +34.4% | 15,988 | +33.4% | 1.54% | +19.2% |
| IONS | Sell | IONIS PHARMACEUTICALS INC | $5,339,658 | -26.5% | 141,373 | -13.9% | 1.22% | -34.8% |
| CVS | CVS HEALTH CORP | $4,048,453 | -2.3% | 43,443 | 0.0% | 0.93% | -13.3% | |
| BNTX | New | BIONTECH SEsponsored ads | $3,565,922 | – | 23,738 | +100.0% | 0.82% | – |
| PTCT | PTC THERAPEUTICS INC | $3,309,034 | -24.0% | 86,692 | 0.0% | 0.76% | -32.5% | |
| ACAD | New | ACADIA PHARMACEUTICALS INC | $2,958,493 | – | 185,835 | +100.0% | 0.68% | – |
| CTLT | New | CATALENT INC | $2,475,550 | – | 55,000 | +100.0% | 0.57% | – |
| VIR | VIR BIOTECHNOLOGY INC | $2,273,040 | +31.3% | 89,808 | 0.0% | 0.52% | +16.6% | |
| RARE | ULTRAGENYX PHARMACEUTICAL IN | $2,108,942 | +11.9% | 45,520 | 0.0% | 0.48% | -0.8% | |
| Exit | EMBECTA CORP | $0 | – | -5,246 | -100.0% | -0.04% | – | |
| NVAX | Exit | NOVAVAX INC | $0 | – | -56,735 | -100.0% | -0.27% | – |
| ALNY | Exit | ALNYLAM PHARMACEUTICALS INC | $0 | – | -6,921 | -100.0% | -0.36% | – |
| RIGL | Exit | RIGEL PHARMACEUTICALS INC | $0 | – | -1,346,904 | -100.0% | -0.41% | – |
| UHS | Exit | UNIVERSAL HLTH SVCS INCcl b | $0 | – | -27,077 | -100.0% | -0.62% | – |
| ITCI | Exit | INTRA-CELLULAR THERAPIES INC | $0 | – | -68,612 | -100.0% | -0.82% | – |
| SAGE | Exit | SAGE THERAPEUTICS INC | $0 | – | -115,696 | -100.0% | -1.17% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR/A filed 2023-02-08
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BOSTON SCIENTIFIC CORP | 40 | Q1 2023 | 9.9% |
| BIO RAD LABS INC | 40 | Q1 2023 | 4.7% |
| BRISTOL-MYERS SQUIBB CO | 38 | Q3 2023 | 11.9% |
| BAXTER INTL INC | 34 | Q3 2023 | 12.7% |
| CARDINAL HEALTH INC | 34 | Q3 2023 | 8.1% |
| PERKINELMER INC | 33 | Q2 2021 | 6.3% |
| BIOGEN INC | 30 | Q3 2023 | 7.6% |
| ELEVANCE HEALTH INC | 30 | Q3 2023 | 5.6% |
| GILEAD SCIENCES INC | 29 | Q3 2023 | 14.0% |
| TENET HEALTHCARE CORP | 28 | Q3 2023 | 4.3% |
View SECTOR GAMMA AS's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-05 |
| 13F-HR | 2023-11-06 |
| 13F-HR | 2023-08-09 |
| 13F-HR | 2023-05-12 |
| 13F-HR/A | 2023-02-08 |
| 13F-HR | 2023-02-07 |
| 13F-HR | 2022-11-09 |
| 13F-HR | 2022-08-05 |
| 13F-HR | 2022-05-06 |
| 13F-HR | 2022-02-08 |
View SECTOR GAMMA AS's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.